HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin D Supplements For Children Present Overdose Risk, Say French Regulators

Executive Summary

France's food and drug regulators say children should only be given vitamin D in approved drugs after cases were reported of overdose in infants linked to supplement use.

You may also be interested in...



No OTC High Dose Vit D3 Supplements, Say German Doctors After Infant Overdose Case

The Drug Commission of the German Medical Association warns against the unsupervised use of high-dose vitamin D3 supplements after the overdose of a seven-month-old German infant.

French Experts Call For Mass Vitamin D Supplementation To Fight COVID-19

With around half the French population vitamin D deficient, a group of medical experts say mass supplementation is a low cost and low risk intervention which could save lives and curb the spread of COVID-19.

France Warns Supplements Can Interfere With Immune Response To COVID-19

Dietary supplements containing certain plants can inhibit the immune response to COVID-19 and should not be taken by those showing symptoms of the virus, according to French regulator ANSES.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151019

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel